Net profit of Pfizer rose 19.37% to Rs 189.02 crore in the quarter ended September 2025 as against Rs 158.35 crore during the previous quarter ended September 2024. Sales rose 9.13% to Rs 642.34 crore in the quarter ended September 2025 as against Rs 588.59 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 642.34 | 588.59 | 9 |
| OPM % | 35.80 | 32.15 | - |
| PBDT | 269.65 | 230.22 | 17 |
| PBT | 255.37 | 215.23 | 19 |
| NP | 189.02 | 158.35 | 19 |